Skip to main content
. Author manuscript; available in PMC: 2022 Sep 15.
Published in final edited form as: Cancer Immunol Res. 2019 Mar 22;7(5):805–812. doi: 10.1158/2326-6066.CIR-18-0499

Table 1.

Patient and tumor characteristics

Patient/tumor characteristics N (%)
Median age (IQR), years 23.5 (19.5–29.5)
Patient sexa
 Male 9 (41)
 Female 13 (59)
Patient race (white) 22 (100.0)
Location of primary sampleb
 Liver 20 (63)
 Lymph node 2 (6)
 Other metastasis sites 10 (31)
Median tumor size (IQR), cmb 10.0 (3.5–11.2)
Disease recurrence
 No 4 (18)
 Yes 11 (50)
 Unknown 7 (32)
Died during follow-up
 No 8 (36)
 Yes 7 (32)
 Unknown 7 (32)
a

Clinical characteristics only include patients from Johns Hopkins Hospital (n = 22).

b

Analysis presented here on tumor samples. The denominator for these analyses is 32.